NASDAQ: TOCA       Tocagen Inc
Last Price Today's Change   Day's Range   Trading Volume
0.531   -0.191 (26.45%)  0.46 - 0.69  3,769,881


Avg Volume (4 weeks):494,984
4 Weeks Range:0.46 - 0.79
4 Weeks Price Volatility (%):
52 Weeks Range:0.46 - 12.00
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Tocagen Inc is a clinical-stage, cancer-selective gene therapy company. It is focused on developing product candidates designed to activate a patient's immune system against their own cancer from within. The company's cancer-selective gene therapy platform is built on retroviral replicating vectors, or RRVs, which are designed to selectively deliver therapeutic genes into the DNA of cancer cells. Tocagen is developing product candidate, Toca 511 and Toca FC, for the treatment of recurrent high grade glioma, or HGG, a brain cancer with limited treatment options, low survival rates and, therefore, a significant unmet medical need. The company has obtained Fast Track Designation from the U.S. Food and Drug Administration for Toca 511 and Toca FC.

  Be the first to like this.


3640  2100  313  2918 

Top 10 Active Counters
 CELG 108.24+0.11 
 GE 11.44+0.47 
 AMD 42.59+3.12 
 DHR 151.30+1.63 
 CHK 0.783+0.037 
 BAC 34.68+1.04 
 FCEL 0.707+0.144 
 AMRX 5.04+1.56 
 AABA 19.630.00 
 F 9.32+0.21 
Partners & Brokers